Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,786.00    26.00 (0.69%)
Bid:
3,782.00
Ask:
3,792.00
Spread: 10.00 (0.264%)
Market Cap: £1.06b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

AGM Statement

6 May 2015 11:00

RNS Number : 3454M
4imprint Group PLC
06 May 2015
 

6 May 2015

 

4imprint Group plc

 

AGM Trading Statement

 

4imprint Group plc ("the Group"), the leading direct marketer of promotional products, today holds its Annual General Meeting of shareholders at which John Poulter, Chairman, is making the following remarks:

 

"The Group has built a strong position in a large but still highly fragmented market, and its overall business strategy remains unchanged. Profit growth will be driven by continuing to reinvest in marketing to expand market share and to grow revenue rapidly, while maintaining a broadly constant operating margin percentage.

 

Trading in the first four months of the year has been encouraging, with revenues 20.7% ahead of the comparative prior year period and order intake 21.8% ahead, with a good balance between order levels from new and existing customers.

 

Although it is still early in the year, indications are positive for the Group's half and full year performance, in keeping with the strategy."

 

 

For further information please contact:

 

4imprint Group plc

Tel: +44 (0) 20 7299 7201

 

MHP Communications

Tel: +44 (0) 20 3128 8100

Kevin Lyons-Tarr

Chief Executive

 

Reg Hoare

David Seekings

Chief Financial Officer

Katie Hunt

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUNVKRVNAVRRR
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.